BioAdaptives, Inc.
BDPT · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.04 | 0.03 | -0.00 |
| FCF Yield | -42.34% | -22.59% | -10.83% | -16.91% |
| EV / EBITDA | -2.60 | -4.78 | -4.85 | -2.21 |
| Quality | ||||
| ROIC | 24.74% | 35.25% | 20.28% | 30.10% |
| Gross Margin | 83.14% | 33.02% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.40 | 0.70 | 0.50 | 0.27 |
| Growth | ||||
| Revenue 3-Year CAGR | -32.34% | – | – | – |
| Free Cash Flow Growth | -17.31% | -31.74% | 2.62% | -78.46% |
| Safety | ||||
| Net Debt / EBITDA | -1.25 | -0.90 | -1.22 | -0.57 |
| Interest Coverage | 18.77 | -28.94 | -25.81 | -34.79 |
| Efficiency | ||||
| Inventory Turnover | 0.02 | 0.05 | 0.00 | 1.04 |
| Cash Conversion Cycle | 5,097.84 | 1,259.12 | 0.00 | 59.20 |